Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | RXRA | P19793 | 5/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.43 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.41 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.41 |
| ▸ | MAT2A | P31153 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17459254 | 0.85 | RXRA (0.53) | RXRAGRIN1GRIN2B | |
| SCHEMBL17459261 | 0.80 | RXRA (0.40) | CYP1A2RXRAGRIN1GRIN2BNPC1 | |
| SCHEMBL17459259 | 0.76 | CYP1A2 (0.53) | CYP1A2BRD9NPBWR1MCHR1NPC1 | |
| SCHEMBL11573132 | 0.73 | L3MBTL1 (0.50) | CYP1A2NPC1RAB9AMAPTMEN1 | |
| SCHEMBL4293579 | 0.69 | CYP1A2 (0.57) | CYP1A2BRD9MEN1KMT2AGAA | |
| SCHEMBL17459260 | 0.69 | CYP1A2 (0.50) | CYP1A2BRD9MEN1KMT2AGAA | |
| SCHEMBL17537376 | 0.67 | CYP1A2 (0.58) | CYP1A2BRD9MAPTMEN1KMT2A | |
| SCHEMBL11724266 | 0.67 | NPC1 (0.60) | CYP1A2NPBWR1MCHR1NPC1RAB9A | |
| SCHEMBL28744539 | 0.66 | CYP1A2 (0.48) | CYP1A2BRD9MAT2AMEN1KMT2A | |
| SCHEMBL31532178 | 0.66 | ALOX5AP (0.45) | CYP1A2MAPTMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963442-B2 | Pyridones as herbicides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2018-05-08 | — | — | US | claimed |
| US-20170204081-A1 | PYRIDONES AS HERBICIDES | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-07-20 | — | — | US | claimed |
| EP-3171698-A1 | PYRIDONES AS HERBICIDES | E. I. du Pont de Nemours and Company (US) | 2017-05-31 | — | — | EP | claimed |
| WO-2016014814-A1 | PYRIDONES AS HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-01-28 | — | — | WO | claimed |
| US-9963442-B2 | Pyridones as herbicides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2018-05-08 | — | — | US | disclosed |
| US-20170204081-A1 | PYRIDONES AS HERBICIDES | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-07-20 | — | — | US | disclosed |
| EP-3171698-A1 | PYRIDONES AS HERBICIDES | E. I. du Pont de Nemours and Company (US) | 2017-05-31 | — | — | EP | disclosed |
| WO-2016014814-A1 | PYRIDONES AS HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204081-A1 | PYRIDONES AS HERBICIDES | CYP1B1, PNPO, CYP1A1 | CYP1A2 8/4885RXRA 392/4885GRIN1 709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.